Cite
HARVARD Citation
van Rhee, F. et al. (2020). Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials. Lancet. 7 (3), pp. e209-e217. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
van Rhee, F. et al. (2020). Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials. Lancet. 7 (3), pp. e209-e217. [Online].